Here’s why I think Dr. Menon decided on 250 & 35
Post# of 72430
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
250 mg/m2 - the near disappearance of the spleen lesion in the ovarian cancer patient was due to 215 mg/m2 of K at once per week for three cycles.
350 mg/m2 - the slight tumor reduction in the thymoma cancer patient was due to 350 mg/m2 of K at once per week.
250 mg/m2 is well within the expected efficacy range of 200-300 mg/m2 according to Dr. Menon. Bashers said don’t expect to see any tumor response. If IPIX doesn’t think K might have an effect in tumors, they wouldn’t include efficacy as secondary endpoint (wasted time and money).
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)